期刊文献+

脂蛋白相关磷脂酶A2酶活性及其基因R92H多态性与冠心病的相关性研究 被引量:3

下载PDF
导出
摘要 目的探讨脂蛋白相关磷脂酶A2(Lp-PLA2)酶活性及其基因R92H多态性与冠心病的相关关系。方法选取深圳恒生医院及深圳市孙逸仙心血管医院经冠状动脉造影确诊为冠心病的患者120例纳入观察组。根据累及支数定义为单支病变、多支病变,并作Gensini评分。另取同期深圳恒生医院120例健康体检者纳入对照组。分别检测受试者Lp-PLA2水平及其基因R92H多态性情况,并进行对比分析。结果观察组血清Lp-PLA2水平明显高于对照组,差异有统计学意义(P<0.05);而观察组患者随着病变程度及Gensini积分的不断增加,Lp-PLA2水平也呈逐渐上升趋势,差异均有统计学意义(P<0.05)。观察组RR基因型人数所占比例明显低于对照组,差异有统计学意义(P<0.05)。在观察组中,RR基因型患者的多支病变人数所占比例及Gensini积分明显低于RH+HH基因型患者,差异均有统计学意义(P<0.05)。结论 Lp-PLA2水平及其基因R92H多态性与冠心病存在密切相关性。
出处 《国际检验医学杂志》 CAS 2018年第4期498-500,共3页 International Journal of Laboratory Medicine
基金 深圳市科技研发资金资助项目(JCYJ20150402115458642)
  • 相关文献

参考文献10

二级参考文献83

  • 1徐敏,孙建辉,罗光华,白江涛,刘亚平,柯海燕.脂蛋白相关磷脂酶A2基因R92H多态性与汉族人群冠心病易感性的关系[J].中国动脉硬化杂志,2008,16(12):965-968. 被引量:3
  • 2胡蓉,方先松,江丽霞,曹娟.冠心病患者血清Lp-PLA2及hs-CRP水平与冠状动脉粥样硬化易损斑块的相关性[J].中国老年学杂志,2015,35(1):74-75. 被引量:37
  • 3J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 4亢爱春,霍勇,齐丽彤.溶血磷脂酰胆碱在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2006,14(12):1083-1086. 被引量:26
  • 5Packard CJ, O' Reilly DS, Caslake MJ, et al. Lipoprotein- associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med,2000,343 : ! 148-1155.
  • 6Koenig W, Khuseyinova N, Lowel H, et al. Lipoprotein- associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle- aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation, 2004,110 : 1903-1908.
  • 7May HT, Horne BD, Anderson JL, et al. Lipoprotein-assoeiated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death. Am Heart J,2006,152:997-1003.
  • 8Garza CA, Montori VM, Mcconnell JP, et al. between lipoprotein-associated phospholipase cardiovascular disease: a systematic review. Mayo 2007,82 : 159-165. Association A2 and.
  • 9Koenig W, Khuseyinova N. Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence. Cardiovasc Drugs Ther,2009,23:85-92.
  • 10Koenig W, Twardella D, Brenner H, et al. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol, 2006, 26: 1586-1593.

共引文献121

同被引文献25

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部